The Chemours Company CC
$14.58
-$0.45-2.99%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.91% | 0.55% | 0.43% | 0.02% | 0.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.91% | 0.55% | 0.43% | 0.02% | 0.60% |
| Cost of Revenue | 2.51% | 5.18% | 5.60% | 2.55% | 1.92% |
| Gross Profit | -16.24% | -19.27% | -20.56% | -10.50% | -4.91% |
| SG&A Expenses | 2.94% | -19.60% | -25.45% | -1.26% | 4.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.43% | 2.29% | 1.90% | 2.07% | 2.15% |
| Operating Income | -49.47% | -23.90% | -18.47% | -23.50% | -17.54% |
| Income Before Tax | 86.07% | -872.97% | -346.73% | -618.42% | -437.35% |
| Income Tax Expenses | 79.73% | 376.92% | 229.73% | 596.43% | 648.15% |
| Earnings from Continuing Operations | 28.74% | -3,827.27% | -651.43% | -609.09% | -489.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00% | -- | -- | 50.00% | 50.00% |
| Net Income | 29.14% | -3,827.27% | -651.43% | -626.56% | -497.22% |
| EBIT | -49.47% | -23.90% | -18.47% | -23.50% | -17.54% |
| EBITDA | -24.32% | -6.77% | -0.85% | -9.08% | -6.39% |
| EPS Basic | 29.62% | -3,771.47% | -646.60% | -622.76% | -494.72% |
| Normalized Basic EPS | -112.19% | -49.89% | -43.72% | -46.59% | -37.72% |
| EPS Diluted | 29.61% | -4,938.41% | -672.30% | -660.96% | -509.01% |
| Normalized Diluted EPS | -112.29% | -49.87% | -43.57% | -46.47% | -37.33% |
| Average Basic Shares Outstanding | 0.52% | 0.49% | 0.50% | 0.55% | 0.63% |
| Average Diluted Shares Outstanding | 0.59% | 0.45% | 0.28% | 0.34% | 0.08% |
| Dividend Per Share | -58.21% | -65.00% | -48.75% | -32.50% | -16.25% |
| Payout Ratio | 0.39% | -1.01% | -1.10% | -1.13% | -1.21% |